Clinical Trials Directory

Trials / Conditions / Recurrent Colon Carcinoma

Recurrent Colon Carcinoma

11 registered clinical trials studyying Recurrent Colon Carcinoma.

StatusTrialSponsorPhase
TerminatedHeated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatr
NCT04213794
Mayo ClinicEARLY_Phase 1
Active Not RecruitingTAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer
NCT04294264
Rutgers, The State University of New JerseyPhase 2
CompletedS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally
NCT03365882
SWOG Cancer Research NetworkPhase 2
Active Not RecruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymph
NCT02465060
National Cancer Institute (NCI)Phase 2
CompletedNintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
NCT02393755
Roswell Park Cancer InstitutePhase 1 / Phase 2
TerminatedA Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Ca
NCT01729923
University of WashingtonPhase 2
CompletedAkt Inhibitor MK2206 in Treating Patients With Previously Treated Colon or Rectal Cancer That is Metastatic or
NCT01802320
National Cancer Institute (NCI)Phase 2
CompletedSorafenib Tosylate, Bevacizumab, Irinotecan Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Pa
NCT01383343
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
NCT01254617
National Cancer Institute (NCI)Phase 1
TerminatedPhase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer
NCT01198535
National Cancer Institute (NCI)Phase 1
CompletedGamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors
NCT01131234
National Cancer Institute (NCI)Phase 1